Science Driven. Nature Inspired. Future Focused.

A deep-tech biopharmaceutical company grounded in Asian medicinal heritage — not a traditional TCM practitioner, but a science-driven innovator advancing nature-derived therapeutics.

What We Do

Nanyang Biologics advances modern healthcare by blending biological science, computational innovation and natural-origin insights.

We continue to expand our work into
emerging areas of discovery and development.

Therapeutics

Exploring future therapies shaped by biology, data and nature

NYB is progressing early-stage therapeutic candidates informed by our discovery platform and botanical heritage. Research areas include metabolic health, inflammation and oncology. These programmes remain in development and continue to evolve as evidence emerges.

NYB-AI Drug Discovery Platform (DTIGN)

AI-led discovery inspired by nature

DTIGN analyses biological, chemical and botanical data to surface novel therapeutic leads with greater speed and clarity. The platform accelerates hypothesis generation, derisks early decisions and enables nature-informed drug design.

Nutraceuticals

Clinically guided, nature-derived formulations

CareViva develops nutraceutical products shaped by plant-based science, safety considerations and culturally rooted knowledge. These formulations aim to support wellness through carefully selected bioactive ingredients.

Featured news

Technology

Introducing LigoSpace: Advancing Bioactivity Prediction at NeurIPS 2025

Nanyang Biologics is excited to share that its latest research, LigoSpace, developed in collaboration with Nanyang Technological University Singapore (NTU), has been presented at NeurIPS 2025, one of the world’s most prestigious conferences in AI and ML.
Partnership

Nanyang Biologics Announces $1.5 Billion Business Combination with RF Acquisition Corp II to Pursue Nasdaq Listing

Nanyang Biologics announced the signing of a business combination agreement with RF Acquisition Corp II, aiming to bring NYB to the public markets.
Partnership

Powering Life Sciences and Health Innovation - A Global AI Alliance from Singapore

Nanyang Biologics hosts AI4Life Summit 2025 with global partners – NVIDIA, Hewlett Packard Enterprise, and Equinix – to accelerate AI-Driven biomedical innovation

New Visitor Navigation

New to Nanyang Biologics? Start here to explore our technology, our heritage
and how we transform nature’s wisdom into future healthcare solutions.

If you are looking
for AI drug discovery partners….
If you are looking for nutraceutical distribution partnerships…